165 related articles for article (PubMed ID: 12650784)
1. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.
Liu J; Manheimer E; Tsutani K; Gluud C
Am J Gastroenterol; 2003 Mar; 98(3):538-44. PubMed ID: 12650784
[TBL] [Abstract][Full Text] [Related]
2. Medicinal herbs for hepatitis C virus infection.
Liu JP; Manheimer E; Tsutani K; Gluud C
Cochrane Database Syst Rev; 2001; 2001(4):CD003183. PubMed ID: 11687177
[TBL] [Abstract][Full Text] [Related]
3. Chinese medicinal herbs for chronic hepatitis B.
Liu JP; McIntosh H; Lin H
Cochrane Database Syst Rev; 2001; 2000(1):CD001940. PubMed ID: 11279742
[TBL] [Abstract][Full Text] [Related]
4. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
5. [Compound Chinese herbal medicines, Chinese herbal drugs and their active extracts for treatment of chronic hepatitis C: a systematic review and meta-analysis of randomized clinical trials].
Qin XK; Han M; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2009 Oct; 7(10):913-28. PubMed ID: 19828101
[TBL] [Abstract][Full Text] [Related]
6. Chinese medicinal herbs for chronic hepatitis B: a systematic review.
Liu J; McIntosh H; Lin H
Liver; 2001 Aug; 21(4):280-6. PubMed ID: 11454192
[TBL] [Abstract][Full Text] [Related]
7. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection.
Liu JP; McIntosh H; Lin H
Cochrane Database Syst Rev; 2001; 2001(2):CD002231. PubMed ID: 11406038
[TBL] [Abstract][Full Text] [Related]
8. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
Cochrane Database Syst Rev; 2012 Sep; (9):CD008516. PubMed ID: 22972122
[TBL] [Abstract][Full Text] [Related]
9. Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review.
Liu J; Lin H; McIntosh H
J Viral Hepat; 2001 Sep; 8(5):358-66. PubMed ID: 11555193
[TBL] [Abstract][Full Text] [Related]
10. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
Brok J; Gluud LL; Gluud C
Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
[TBL] [Abstract][Full Text] [Related]
11. Oral traditional Chinese medication for adhesive small bowel obstruction.
Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
[TBL] [Abstract][Full Text] [Related]
12. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
[TBL] [Abstract][Full Text] [Related]
13. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
[TBL] [Abstract][Full Text] [Related]
14. Medicinal plants against hepatitis C virus.
Ashfaq UA; Idrees S
World J Gastroenterol; 2014 Mar; 20(11):2941-7. PubMed ID: 24659884
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation.
Mukherjee S; Rogge J; Weaver L; Schafer DF
Transplant Proc; 2003 Dec; 35(8):3042-4. PubMed ID: 14697974
[TBL] [Abstract][Full Text] [Related]
16. Chinese medicinal herbs for cholelithiasis.
Gan T; Chen J; Jin SJ; Wang Y
Cochrane Database Syst Rev; 2013 Jun; (6):CD004547. PubMed ID: 23813425
[TBL] [Abstract][Full Text] [Related]
17. Herbal medicines for fatty liver diseases.
Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
[TBL] [Abstract][Full Text] [Related]
18. [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study].
Pár A; Roth E; Miseta A; Hegedüs G; Pár G; Hunyady B; Vincze A
Orv Hetil; 2009 Jan; 150(2):73-9. PubMed ID: 19103558
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients.
Chen J; Shi J; Xie WF; Zeng X; Lin Y
Int J Infect Dis; 2012 Oct; 16(10):e748-52. PubMed ID: 22836046
[TBL] [Abstract][Full Text] [Related]
20. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
Gordon CE; Uhlig K; Lau J; Schmid CH; Levey AS; Wong JB
Am J Kidney Dis; 2008 Feb; 51(2):263-77. PubMed ID: 18215704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
